Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Withdrawn applications
Get the latest updates from Withdrawn applications directly as they happen.
Follow now 198 followers
Latest posts
Last updated about 2 months ago
Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn
about 2 months ago
Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn
about 2 months ago
Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes...
Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn
about 2 months ago
Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status...
Withdrawn application: Brilique, 15/12/2021
2 months ago
Withdrawn application: Brilique, 15/12/2021
Withdrawn application: Vectra 3D, 27/11/2024
2 months ago
Withdrawn application: Vectra 3D, 27/11/2024
Human medicines European public assessment report (EPAR): Ohtuvayre, ensifentrine, Status: Application withdrawn
3 months ago
Human medicines European public assessment report (EPAR): Ohtuvayre, ensifentrine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Insulin Aspart Injection, insulin aspart, Status: Application withdrawn
3 months ago
Human medicines European public assessment report (EPAR): Insulin Aspart Injection, insulin aspart...
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn
3 months ago
Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Datopotamab deruxtecan Daiichi Sankyo, datopotamab deruxtecan, Status: Application withdrawn
3 months ago
Human medicines European public assessment report (EPAR): Datopotamab deruxtecan Daiichi Sankyo, datopotamab...
Human medicines European public assessment report (EPAR): Insulin Human Rechon, insulin human, Status: Application withdrawn
3 months ago
Human medicines European public assessment report (EPAR): Insulin Human Rechon, insulin human...
Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn
4 months ago
Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn